You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adalimumab

Showing 26 - 50 of 218
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ulcerative Colitis Trial (MTX 12.5, MTX 25, Adalimumab)

Terminated
Has Results
  • Ulcerative Colitis
  • MTX 12.5
  • +2 more
  • (no location specified)
Jun 1, 2021

Uveitis Trial (Adalimumab, Prednisone, Placebo)

Completed
Has Results
  • Uveitis
  • Adalimumab
  • +2 more
  • (no location specified)
Jul 2, 2021

Crohn's Disease Trial (BT-11 (Omilancor), adalimumab)

Withdrawn
  • Crohn's Disease
  • BT-11 (Omilancor)
  • adalimumab
  • (no location specified)
Mar 10, 2022

Arthritis, Psoriatic Trial in Bulgaria, Poland, United States (Sonelokimab, Placebo, Adalimumab)

Recruiting
  • Arthritis, Psoriatic
  • Rancho Mirage, California
  • +10 more
Jan 24, 2023

Rheumatoid Arthritis Trial in Leiden (Filgotinib, Adalimumab)

Not yet recruiting
  • Rheumatoid Arthritis
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Aug 14, 2022

Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)

Recruiting
  • Skin Inflammation
  • Allergic Contact Dermatitis
  • Squaric Acid Dibutyl Ester
  • +12 more
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Sep 6, 2022

Rheumatoid Arthritis, Cardiovascular Disease Trial in San Francisco (Adalimumab, Placebo)

Completed
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Adalimumab
  • Placebo
  • San Francisco, California
    University of California San Francisco/San Francisco General Hos
Apr 7, 2021

Crohn Disease, IBD Trial in Netherlands (Adalimumab, standard step-up care)

Recruiting
  • Crohn Disease
  • Inflammatory Bowel Diseases
  • Adalimumab
  • standard step-up care
  • Maastricht, Netherlands
  • +4 more
May 18, 2021

Rheumatoid Arthritis Trial in France, Monaco (baricitinib treatment, adalimumab, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • baricitinib treatment
  • +2 more
  • Belfort, France
  • +28 more
Mar 3, 2022

Rheumatoid Arthritis Trial (Upadacitinib, Adalimumab)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Nov 29, 2021

FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

Recruiting
  • FSGS
  • +3 more
  • adalimumab
  • Ann Arbor, Michigan
  • +3 more
Jan 31, 2022

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Rheumatoid Arthritis Trial in Japan, Korea, Republic of, Taiwan (Methotrexate, Adalimumab)

Active, not recruiting
  • Rheumatoid Arthritis
  • Aichi, Japan
  • +23 more
Aug 31, 2021

Rheumatoid Arthritis Trial (Adalimumab, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Adalimumab
  • Placebo
  • (no location specified)
Oct 21, 2021

Precision Crohn's Disease Management Utilizing Predictive

Active, not recruiting
  • Crohn's Disease
  • IBD
  • Hartford, Connecticut
  • +3 more
Feb 10, 2022

Rheumatoid Arthritis, Myocardial Inflammation Trial in New York (Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Myocardial Inflammation
  • New York, New York
    Columbia University Medical Center
Aug 2, 2021

Ulcerative Colitis Trial in France (drug, diagnostic test, other)

Recruiting
  • Ulcerative Colitis
  • Adalimumab
  • +3 more
  • Cholet, Maine Et Loire, France
  • +21 more
Jun 28, 2021

Rheumatoid Arthritis Trial in Amsterdam (Adalimumab serum trough concentration, Disease activity, Adalimumab)

Unknown status
  • Rheumatoid Arthritis
  • Adalimumab serum trough concentration
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
    Reade Rheumatology Research Institute
Oct 13, 2020

Crohn Disease Trial in Canada, United States (Vedolizumab, Adalimumab, Methotrexate)

Completed
Has Results
  • Crohn Disease
  • Dothan, Alabama
  • +31 more
Jul 11, 2022

Spondylitis, Ankylosing Trial in France (Adalimumab)

Completed
  • Spondylitis, Ankylosing
  • Adalimumab
  • Belfort, France
  • +4 more
Mar 16, 2021

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Adalimumab, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • Fullerton, California
  • +76 more
Aug 12, 2022

Sarcoidosis Trial in Chicago (Adalimumab)

Terminated
Has Results
  • Sarcoidosis
  • Adalimumab
  • Chicago, Illinois
    The University of Chicago
Aug 21, 2020

Rheumatoid Arthritis Trial in Amsterdam (Dose reduction to 2mg/L, Dose reduction to 5mg/L, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Dose reduction to 2mg/L
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
    Reade Rheumatology Research Institute
Oct 13, 2020

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))

Completed
Has Results
  • Rheumatoid Arthritis
  • Covina, California
  • +85 more
Mar 15, 2022